Hormone replacement therapy [topp]
Nitric Oxide [bacs, inch, phsu]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Levels [qlco]
vascular inflammation [dsyn]
Play [dora]
pathogenesis [ftcn]
Atherosclerosis [dsyn]
investigated [ftcn]
Hormone replacement therapy [topp]
Vasomotor function [ortf]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Levels [qlco]
Serological [ftcn]
Marker [clna]
Inflammation [patf]
Methods [inpr]
Administered [ftcn]
Progesterone 200 MG [clnd]
10 days [tmco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
mg% [qnco]
days [tmco]
Remaining [qlco]
days [tmco]
2 Months [tmco]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Measured [qlco]
Plasma [bdsu]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Measured [qlco]
Plasma [bdsu]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Subject [grup]
premenopausal [tmco]
Women [popg]
Men [popg]
Men [popg]
progesterone, micronized [horm, phsu, strd]
Combined [qlco]
Conjugated estrogen [horm, phsu, strd]
Equine [mamm]
Improved [qlco]
Percent [qnco]
Flow [npop]
mediated response [menp]
Dilator [medd]
Hyperaemia [patf]
Relative [famg]
baseline [bodm]
measurements [ftcn]
P NOS [aapp, imft]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Levels [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Receive [qlco]
Hormone replacement therapy [topp]
pg/mL [qnco]
P NOS [aapp, imft]
Comparison [acty]
Subject [grup]
Estrogen [horm, phsu, strd]
Status [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Levels [qlco]
Subject [grup]
low estrogen [fndg]
Status [qlco]
P NOS [aapp, imft]
premenopausal [tmco]
Women [popg]
Levels [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Men [popg]
Age [orga]
pg/mL [qnco]
P NOS [aapp, imft]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Levels [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Compared [acty]
Men [popg]
Age [orga]
pg/mL [qnco]
P NOS [aapp, imft]
premenopausal [tmco]
Women [popg]
Markedly [qlco]
Levels [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
pg/mL [qnco]
P NOS [aapp, imft]
postmenopausal [tmco]
Women [popg]
Receive [qlco]
Hormone replacement therapy [topp]
Levels [qlco]
Monocyte Chemoattractant Protein-1 [aapp, imft]
Compared [acty]
premenopausal [tmco]
Women [popg]
pg/mL [qnco]
P NOS [aapp, imft]
findings [ftcn]
Partial [qnco]
Explanation [inpr]
Protection [fndg]
Cardiovascular disease [dsyn]
experience [menp]
premenopausal [tmco]
Women [popg]
Loss [qnco]
Protection [fndg]
Following [tmco]
Menopause [phsf]
Science [ocdi]
Ireland [geoa]
LTD [ortf]
Reserve [acty]
